Fresenius

Bad Homburg, Germany Founded: 1912 • Age: 114 yrs Listed
System-critical products and services for healthcare therapies are provided.

About Fresenius

Fresenius is a publicly listed company based in Bad Homburg (Germany) founded in 1912 by Eduard Fresenius. System-critical products and services for healthcare therapies are provided. Fresenius has raised $50 million across 2 funding rounds from investors including Elliott Management and DW Management Services. The company has 37 employees. Fresenius has completed 6 acquisitions, including APP Pharma, Eugin and Quirnsalud. Its chief executive, as recorded, is Stephan Sturm. Its website fresenius.com draws about 59 thousand monthly visits. Its Indian entity Fresenius Digital Technology India Private Limited reported revenue of β‚Ή59.73 Cr. Its focus areas include Traditional Pharmaceuticals and Diversified.

Company details

Fresenius was established in 1912 in Bad Homburg, Germany, within the healthcare sector. Operations encompass IV drugs and fluids, clinical nutrition, biopharma, transfusion and cell therapies, and infusion systems. Expansion efforts target home dialysis treatments, while digitalization is utilized to enable personalized care. In 2022, annual revenues reached 42.71B, with a net profit of 1.44B recorded. Global reach supports therapy-focused services.

  • Headquarters Bad Homburg, Germany
  • Employees 37
  • Founders Eduard Fresenius
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website fresenius.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Fresenius Se & Co. Kgaa
Key Metrics
  • Indian entity revenue
    ₹59.73 Cr

    FY 2026 · +54% YoY

  • Indian entity net profit
    ₹5.74 Cr

    FY 2026 · 10% margin

  • Indian entity EBITDA
    ₹8.25 Cr

    FY 2026 · 14% margin

  • Total Equity Funding
    $50M (USD)

    in 2 rounds

  • Investors
  • Employee Count
    37
  • Investments & Acquisitions
    APP Pharma

    & 5 more

Apps and channels of Fresenius

its YouTube channel Fresenius Group has 5.99K subscribers and 30 videos.

Fresenius Group
YouTube 5.99K subscribers 30 videos Howto & Style
Open channel

Videos from Fresenius

The most watched videos on Fresenius's YouTube channel, Fresenius Group (5.99K subscribers). Click a video to play it here.

Careers With a Purpose at Fresenius Kabi
5.5K views
Fresenius Annual General Meeting 2023 - Speech of the CEO (Translation)
3.9K views
Video Message from Michael Sen
3.4K views
Explanatory video: The Healthcare of Tomorrow
3.1K views

More on Fresenius Group.

Funding Insights of Fresenius

Fresenius has successfully raised a total of $50M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $50M
  • Total Rounds 2
  • First Round $50M

    (Jan 2008)

  • Investors Count 2

All 2 funding rounds of Fresenius with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2022Post-IPO––
Jan 2008$50MPrivate Equity Round––
Valuation history

2 investors in total: 2 institutional.

Investors in Fresenius

Fresenius has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Elliott Management and DW Management Services.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
dwhp.com
Multiple sectors are invested in by the hedge fund.
1977elliottmgmt.comNew York, United States
Premium access

Investor details for Fresenius

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Fresenius Digital Technology India Private Limited (Fresenius)

Fresenius Digital Technology India Private Limited is the primary company behind Fresenius. The board of Fresenius Digital Technology India Private Limited currently have 2 directors; the longest-serving is Ashutosh Kumar, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Ashutosh Kumar
DIN 08030602
Director06 Sep 20215 yrs 2 moFresenius Digital Technology India Private Limited
Manish Kumar
DIN 09308264
Managing Director06 Sep 20215 yrs 2 moFresenius Digital Technology India Private Limited

People of Fresenius

94 people are tracked at Fresenius (45 in leadership, 13 in board & advisors, 36 in team); the tracked headcount is 37.

NameRoleGroup
Eduard Fresenius
FounderLeadership
Stephan Sturm
Co-CEOLeadership
Michael Sen
Co-CEOLeadership
Niklas Schemken
Director Corporate StrategyLeadership
Thomas Musseleck
Director, Head Of Risk Management OperationsLeadership
Sara Hennicken
CFOLeadership
Florian Feick
Deputy Head Of Investor Relations / Head Of Equity Capital Markets (ecm)Leadership
Michael Otto
Director Investor RelationsLeadership
Axel Faupel
Director Group ESGLeadership
Sonja Steppan
Vice President Head Research OfficeLeadership
Robert Möller
CEO Fresenius HeliosLeadership
Elisabeth Truckenbrodt
Director Investor Relations & SustainabilityLeadership
Katja Bajic
Director Group ControllingLeadership
Robert Horvath
Vice President - Strategic Finance TransformationLeadership
Thomas Neidert
Senior Vice President Global Treasury & Corporate FinanceLeadership
Michael Berberich
Vice President Group Risk Management & ICSLeadership
Dr. Anna Lena Lieblein
VP Corporate TransformationLeadership
Sabine H. Scholz
Senior Vice President Internal AuditLeadership
Elisabeth Thäter
Head Of Employer BrandingLeadership
Juliane Beckmann
Vice President, Head Of Corporate FinanceLeadership

74 more people are available in the full profile.

Premium access

Complete people profiles for Fresenius

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Fresenius

Fresenius is a publicly listed company on the XETR with ticker symbol FRE in Germany, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date24 Jul 1998
  • Listed onFRA: FME
  • Listed entityFresenius SE & Co. KGaA
  • Exchange sectorHealth services
  • ISINDE000FRE5EN2
  • Share price43.14 EUR (+0.79% on the day) · 2026-10-14
  • Market capitalisation23,863,131,215.00 EUR
  • Price to earnings16.0
  • EPS (diluted, trailing year)2.70 EUR
  • Dividend yield2.45%
  • Volume (last session)124,337

Financials of Fresenius

Figures of Fresenius Digital Technology India Private Limited, the primary company behind Fresenius, for FY 2026. Revenue was ₹59.73 Cr (+54% year on year). Net profit was ₹5.74 Cr (10% margin). EBITDA was ₹8.25 Cr (14% margin). Revenue has grown at a compounded annual rate of +65% over three years and 0% over five years.

  • ₹59.73 CrRevenue · FY 2026 · +54% YoY
  • ₹5.74 CrNet profit · 10% margin
  • ₹8.25 CrEBITDA · 14% margin
  • ₹26.5 LakhPaid-up capital
  • 37Employees (provident fund records)
  • +65%Revenue CAGR, 3 years
  • 0%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202522.87B EUR1.26B EUR3.30B EUR
202421.95B EUR471.0M EUR3.37B EUR
202321.07B EUR-594.0M EUR2.74B EUR
202221.33B EUR1.37B EUR2.65B EUR
202137.08B EUR1.82B EUR6.25B EUR

Balance sheet, profit and loss, cash flow and ratios of Fresenius Digital Technology India Private Limited are on its company page.

Premium access

Detailed financial statements for Fresenius

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fresenius

Fresenius has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include APP Pharma, Eugin and Quirnsalud.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Fertility treatments are delivered by standalone clinic in Barcelona.
eugin.netBarcelona, Spain1999Dec 2020$525M
Multispecialty hospital services are provided through a network.
quironsalud.esMadrid, Spain2015Sep 2016$6.42B
Management services for acute care healthcare providers are offered.
soundphysicians.comTacoma, United States2001Jun 2014$600M
Injectable pharmaceuticals are manufactured and distributed by APP Pharma.
apppharma.comSchaumburg, United States2002Jul 2008$4.6B
Sorbents for renal replacement therapy are developed using regenerative technology.
renalsolutionsinc.comWarrendale, United States2000Nov 2007$200M
Dialysis clinics are operated nationwide in the United States.
renalcp.comHollywood, United States2002May 2005$3.5B
Premium access

Complete acquisition details for Fresenius

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Fresenius

10 dated milestones of Fresenius across 110 years, from founding to its latest funding, stage changes and deals.

  1. Founded Fresenius is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Renal Care Partners.
  4. Acquisition Acquires Renal Solutions.
  5. Funding First funding round of $50.0M.
  6. Acquisition Acquires APP Pharma.
  7. Acquisition Acquires Sound Physicians.
  8. Acquisition Acquires Quirnsalud.
  9. Acquisition Acquires Eugin.
  10. Funding Latest funding round, Post-IPO,.

Web traffic of Fresenius

The website of Fresenius (fresenius.com) receives about 59.2K visits a month.

  • Monthly visits
    59.2K

    ▲ 2.2% vs previous month

Similar websites

Websites whose visitors overlap most with Fresenius. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
fmc-ag.com
fmc-ag.com
100%
–
fmcna.com
87%
122.1K#184,823View details
fresenius-kabi.com
86%
#218,714View details
freseniusmedicalcare.com
83%
523.8K#109,578View details
nephrocare.com
82%
45.8K#711,548View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 19 similar websites and full traffic analytics for Fresenius

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fresenius

Premium access

Complete news archive for Fresenius

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fresenius

Fresenius was founded in 1912 and raised its 1st funding round 96 years after it was founded.

Fresenius is headquartered in Bad Homburg, Germany. It is registered at Bad Homburg, Hesse, Germany.

Stephan Sturm is the CEO of Fresenius, as recorded in our data.

Fresenius is a funded company, having raised a total of $50M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $50M, raised on Jan 2008.

Fresenius has 37 employees.

The primary company behind Fresenius, Fresenius Digital Technology India Private Limited, reported revenue of β‚Ή59.73 Cr for FY 2026, up 54% year on year.

Fresenius was established in 1912 in Bad Homburg, Germany, within the healthcare sector. Operations encompass IV drugs and fluids, clinical nutrition, biopharma, transfusion and cell therapies, and infusion systems. Expansion efforts target home dialysis treatments, while digitalization is utilized to enable personalized care. In 2022, annual revenues reached 42.71B, with a net profit of 1.44B recorded. Global reach supports therapy-focused services.

Yes, Fresenius is publicly traded on XETR under the ticker symbol FRE.

Fresenius has made 6 acquisitions, including APP Pharma, Eugin, and Quirnsalud.

Fresenius has 2 investors. Key investors include Elliott Management, and DW Management Services.

Fresenius operates through Fresenius Digital Technology India Private Limited.

The legal entities of Fresenius currently have 2 directors, including Ashutosh Kumar, Manish Kumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available